Study2011

Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells

Clarke JD, Hsu A, Yu Z, Dashwood RH, Ho E

Molecular nutrition & food research · 142 citations

Review labels

Mechanisms only

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
In vitro/mechanistic study (classified by our AI screen)
Studied in
Cells or lab samples
Main outcome
Mechanisms only

Who paid for it

Funding
Independent funding
Government
National Cancer Institute
Government
National Institute of Environmental Health Sciences
Government
National Center for Research Resources
Government
NIH
Industry group
Oregon AES
Government
NCI NIH HHS
Government
NCRR NIH HHS
University or hospital
Environmental Health Science Center at Oregon State University
Government
NIEHS NIH HHS
Grants
National Cancer Institute (R01 CA-122906); National Cancer Institute (CA 090890); National Institute of Environmental Health Sciences (P30ES000210); National Institute of Environmental Health Sciences (#P30-ES00210); National Center for Research Resources (S10 RR022589); National Cancer Institute (P01 CA090890); National Center for Research Resources (1S10RR022589); National Cancer Institute (CA122906)

Based on 9 listed funder(s).

Publication

Published
2011-03-04 · Mol Nutr Food Res · vol. 55 · issue 7 · pp. 999–1009
Publisher
Wiley
Cited
178 citations · more than 97% of similar papers · 5.6× the field average
Impact
Top 10% most cited in its field
References
38 works
Access
Open access (repository copy)
Research areas
Genomics, phytochemicals, and oxidative stress · Garlic and Onion Studies · Histone Deacetylase Inhibitors Research
Keywords
Sulforaphane, LNCaP, Cancer research, Prostate cancer, Apoptosis, Acetylation, Histone deacetylase, Cell cycle, Chemistry, Cancer cell, Cell cycle checkpoint, Cancer, Biology, Histone, Internal medicine, Medicine, Biochemistry
MeSH
prostate, cell line, cell line, tumor, cytosol, epithelial cells, humans, prostatic neoplasms, hyperplasia, thiocyanates, isothiocyanates, sulfoxides, tubulin, histone deacetylases, nad(p)h dehydrogenase (quinone), histones, anticarcinogenic agents, cell cycle, apoptosis, acetylation, male, cyclin-dependent kinase inhibitor p21, promoter regions, genetic, histone deacetylase 2, histone deacetylase inhibitors, histone deacetylase 6, histone deacetylase 3

5 authors

From US

  • John ClarkeOregon State University
  • Anna J. C. HsuOregon State University
  • Zhen YuOregon State University
  • Roderick H. DashwoodOregon State University
  • Emily H. Ho · correspondingOregon State University

Abstract

Scope

Sulforaphane (SFN) is an isothiocyanate derived from cruciferous vegetables such as broccoli. The ability of SFN to inhibit histone deacetylase (HDAC) enzymes may be one mechanism by which it acts as a chemoprevention agent. The ability of a chemopreventive agent to specifically cause cytotoxicity in cancer and not normal cells is an important factor in determining its safety and clinical relevance.

Methods and results

We characterized the effects of SFN in normal (PrEC), benign hyperplasia (BPH1) and cancerous (LnCap and PC3) prostate epithelial cells. We observed that 15 μM SFN selectively induced cell cycle arrest and apoptosis in BPH1, LnCap and PC3 cells but not PrEC cells. SFN treatment also selectively decreased HDAC activity, and Class I and II HDAC proteins, increased acetylated histone H3 at the promoter for P21, induced p21 expression and increased tubulin acetylation in prostate cancer cells. HDAC6 over-expression was able to reverse SFN-induced cyotoxicity. In PrEC cells, SFN caused only a transient reduction in HDAC activity with no change in any other endpoints tested. The differences in sensitivity to SFN in PrEC and PC3 are likely not due to differences in SFN metabolism or differences in phase 2 enzyme induction.

Conclusion

SFN exerts differential effects on cell proliferation, HDAC activity and downstream targets in normal and cancer cells.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.